Katrina M. Romagnoli

Katrina M. Romagnoli

Auto-generated profile, based on publicly available information

Katrina M. Romagnoli

Department of Biomedical Informatics, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 January 2013 in BMJ Quality & Safety
Verified
Journal Article
Closed access
PDF file
KRKatrina M Romagnoli
Katrina M Romagnoli
SHSteven M Handler
Steven M Handler
FLFrank M Ligons
Frank M Ligons
HHHarry Hochheiser
Harry Hochheiser
Objective To understand home-care nurses’ perceptions of the post-hospitalisation information needs and communication problems of older patients, and how these factors might contribute to undesirable outcomes including poor patient reintegration into prior living environments and unplanned hospital readmissions. Design A ranked list of information needs experienced by patients was developed by two Nominal Group Technique (NGT) sessions from the perspective of home-care nurses. The list was combined with results from previously published work to develop a web-based survey administered to home-care nurses to elicit perceptions of patients’ post-hospitalisation information needs. Results Seventeen nurses participated in the NGT sessions, producing a list of 28 challenges grouped into five themes: medications, disease/condition, non-medication care/treatment/safety, functional limitations and communication problems. The survey was sent to 220 home-care nurses, with a 54.1% (119/220) response rate. Respondents identified several frequent, high-impact information and communication needs that have received little attention in readmission literature, including information about medication regimens; the severity of their condition; the hospital discharge management process; non-medication care regimens such as wound care, use of durable medical equipment and home safety; the extent of care needed; and which providers are best suited to provide that care. Responses also identified several communication difficulties that may play a role in readmissions. Conclusions Information needs and communication problems identified by home-care nurses expanded upon and reinforced results from prior studies. These results might be used to develop interventions that may improve information sharing among clinicians, patients and caregivers during care transitions to ensure patient reintegration into prior living environments, potentially preventing unplanned hospital readmissions.

12 August 2013 in BMJ Quality & Safety
Verified
Journal Article
Open access
PDF file
KRKatrina M Romagnoli
Katrina M Romagnoli
SHSteven M Handler
Steven M Handler
HHHarry Hochheiser
Harry Hochheiser

22 February 2017 in BMC Medical Informatics and Decision Making
Verified
Journal Article
Open access
PDF file
KRKatrina M. Romagnoli
Katrina M. Romagnoli
SNScott D. Nelson
Scott D. Nelson
LHLisa Hines
Lisa Hines
PEPhilip Empey
Philip Empey
RBRichard D. Boyce
Richard D. Boyce
HHHarry Hochheiser
Harry Hochheiser
Drug information compendia and drug-drug interaction information databases are critical resources for clinicians and pharmacists working to avoid adverse events due to exposure to potential drug-drug interactions (PDDIs). Our goal is to develop information models, annotated data, and search tools that will facilitate the interpretation of PDDI information. To better understand the information needs and work practices of specialists who search and synthesize PDDI evidence for drug information resources, we conducted an inquiry that combined a thematic analysis of published literature with unstructured interviews. Starting from an initial set of relevant articles, we developed search terms and conducted a literature search. Two reviewers conducted a thematic analysis of included articles. Unstructured interviews with drug information experts were conducted and similarly coded. Information needs, work processes, and indicators of potential strengths and weaknesses of information systems were identified. Review of 92 papers and 10 interviews identified 56 categories of information needs related to the interpretation of PDDI information including drug and interaction information; study design; evidence including clinical details, quality and content of reports, and consequences; and potential recommendations. We also identified strengths/weaknesses of PDDI information systems. We identified the kinds of information that might be most effective for summarizing PDDIs. The drug information experts we interviewed had differing goals, suggesting a need for detailed information models and flexible presentations. Several information needs not discussed in previous work were identified, including temporal overlaps in drug administration, biological plausibility of interactions, and assessment of the quality and content of reports. Richly structured depictions of PDDI information may help drug information experts more effectively interpret data and develop recommendations. Effective information models and system designs will be needed to maximize the utility of this information.

1 February 2016 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
KRKatrina M. Romagnoli
Katrina M. Romagnoli
RBRichard D. Boyce
Richard D. Boyce
PEPhilip Empey
Philip Empey
SASolomon Adams
Solomon Adams
HHHarry Hochheiser
Harry Hochheiser

26 February 2017 in Journal of the American Medical Informatics Association
Verified
Journal Article
Open access
PDF file
KRKatrina M Romagnoli
Katrina M Romagnoli
RBRichard D Boyce
Richard D Boyce
PEPhilip Empey
Philip Empey
YNYifan Ning
Yifan Ning
SASolomon Adams
Solomon Adams
HHHarry Hochheiser
Harry Hochheiser
Objective: To develop and evaluate a pharmacogenomics information resource for pharmacists. Materials and Methods: We built a pharmacogenomics information resource presenting Food and Drug Administration (FDA) drug product labelling information, refined it based on feedback from pharmacists, and conducted a comparative usability evaluation, measuring task completion time, task correctness and perceived usability. Tasks involved hypothetical clinical situations requiring interpretation of pharmacogenomics information to determine optimal prescribing for specific patients. Results: Pharmacists were better able to perform certain tasks using the redesigned resource relative to the Pharmacogenomic Knowledgebase (PharmGKB) and the FDA Table of Pharmacogenomic Biomarkers in Drug Labeling. On average, participants completed tasks in 107.5 s using our resource, compared to 188.9 s using PharmGKB and 240.2 s using the FDA table. Using the System Usability Scale, participants rated our resource 79.62 on average, compared to 53.27 for PharmGKB and 50.77 for the FDA table. Participants found the correct answers for 100% of tasks using our resource, compared to 76.9% using PharmGKB and 69.2% using the FDA table. Discussion: We present structured, clinically relevant pharmacogenomic FDA drug product label information with visualizations to help explain the relationships between gene variants, drugs, and phenotypes. The results from our evaluation suggest that user-centered interfaces for pharmacogenomics information can increase ease of access and comprehension. Conclusion: A clinician-focused pharmacogenomics information resource can answer pharmacogenomics-related medication questions faster, more correctly, and more easily than widely used alternatives, as perceived by pharmacists.